192 related articles for article (PubMed ID: 33124455)
1. Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy.
Gaspar A; Silva J; Calderon A; Di Placido V; Vizintin Z
Climacteric; 2020; 23(sup1):S11-S13. PubMed ID: 33124455
[No Abstract] [Full Text] [Related]
2. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
3. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial.
Mackova K; Mazzer AM; Mori Da Cunha M; Hajkova Hympanova L; Urbankova I; Kastelein AW; Vodegel E; Vander Linden K; Fehervary H; Guler Z; Roovers JP; Krofta L; Verhaeghe J; Deprest J
BJOG; 2021 May; 128(6):1087-1096. PubMed ID: 33017509
[TBL] [Abstract][Full Text] [Related]
4. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause.
Gaspar A; Brandi H; Gomez V; Luque D
Lasers Surg Med; 2017 Feb; 49(2):160-168. PubMed ID: 27546524
[TBL] [Abstract][Full Text] [Related]
6. Ablative dual-phase Erbium:YAG laser treatment of atrophy-related vaginal symptoms in post-menopausal breast cancer survivors omitting hormonal treatment.
Mothes AR; Runnebaum M; Runnebaum IB
J Cancer Res Clin Oncol; 2018 May; 144(5):955-960. PubMed ID: 29487993
[TBL] [Abstract][Full Text] [Related]
7. A study of the objective benefits and safety of Er-YAG laser in the treatment of genitourinary syndrome of menopause.
Avul Z; Guven CM
Lasers Med Sci; 2023 Jun; 38(1):131. PubMed ID: 37270721
[TBL] [Abstract][Full Text] [Related]
8. Vaginal laser therapy for GSM/VVA: where we stand now - a review by the EUGA Working Group on Laser.
Salvatore S; Ruffolo AF; Phillips C; Athanasiou S; Cardozo L; Serati M;
Climacteric; 2023 Aug; 26(4):336-352. PubMed ID: 37395104
[TBL] [Abstract][Full Text] [Related]
9. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
10. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
Gambacciani M; Levancini M
Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
[TBL] [Abstract][Full Text] [Related]
11. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
[TBL] [Abstract][Full Text] [Related]
12. Laser Therapy for Genitourinary Syndrome of Menopause.
Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M
Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032
[TBL] [Abstract][Full Text] [Related]
13. Fractional versus ablative erbium:yttrium-aluminum-garnet laser resurfacing for facial rejuvenation: an objective evaluation.
El-Domyati M; Abd-El-Raheem T; Abdel-Wahab H; Medhat W; Hosam W; El-Fakahany H; Al Anwer M
J Am Acad Dermatol; 2013 Jan; 68(1):103-12. PubMed ID: 23110966
[TBL] [Abstract][Full Text] [Related]
14. Lasers in the era of evidence-based medicine.
Hillard TC
Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459
[TBL] [Abstract][Full Text] [Related]
15. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
[TBL] [Abstract][Full Text] [Related]
16. The evidence behind the use of LASER for genitourinary syndrome of menopause, vulvovaginal atrophy, urinary incontinence and lichen sclerosus: A state-of-the-art review.
Mortensen OE; Christensen SE; Løkkegaard E
Acta Obstet Gynecol Scand; 2022 Jun; 101(6):657-692. PubMed ID: 35484706
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
[TBL] [Abstract][Full Text] [Related]
18. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: The VeLVET Trial.
Paraiso MFR; Ferrando CA; Sokol ER; Rardin CR; Matthews CA; Karram MM; Iglesia CB
Menopause; 2020 Jan; 27(1):50-56. PubMed ID: 31574047
[TBL] [Abstract][Full Text] [Related]
19. Correction of nasolabial folds wrinkle using intraoral non-ablative Er:YAG laser.
Ebrahim HM; Gharib K
J Cosmet Laser Ther; 2018 Oct; 20(6):364-368. PubMed ID: 29482388
[No Abstract] [Full Text] [Related]
20. Treatment of Hypertrophic Burn and Traumatic Scars With a 2,940-nm Fractional Ablative Erbium-doped Yttrium Aluminium Garnet Laser: A Pilot Study.
Wulkan AJ; Rudnick A; Badiavas E; Waibel JS
Dermatol Surg; 2020 Jun; 46(6):789-793. PubMed ID: 31876571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
